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Regarding "Prospective randomized comparison of  
surgical versus endovascular management of throm- 
bosed dialysis access grafts" 
To the Editors: 
I read with interest he prospective randomized study 
by Dr. Marston et al. (J Vasc Surg 1997;26:373-81) that 
compared the primary patency rates after surgical and 
endovascular management of thrombosed ialysis grafts. 
This paper undoubtedly will be widely quoted. Neverthe- 
less, the ultimate long-term patency rate of a dialysis access 
has far greater clinical importance than the outcome after 
treatment of a single episode of access thrombosis. If the 
authors believe that radiologic intervention is an inappro- 
priate delay, as suggested by one of the discussants, they 
must prove that repetitive surgical thrombectomy with or 
without revision provides a better patency rate for an 
access than repetitive percutaneous thrombolysis with or 
without angioplasty. A prospective randomized trial would 
require a comparison of the secondary patency rate of a 
repetitive percutaneous treatment arm with a treatment 
arm that used only repetitive surgical thrombectomy with 
or without revision. The surgical arm of such a study 
would have to provide a longer duration of secondary 
patency than the pereutaneous treatment arm to justify 
surgery for all patients with clotted dialysis grafts. This 
outcome is unlikely. In fact, Beathard 1 demonstrated a sig- 
nificant decrease in thepercentage of patients with throm- 
bosis who required graft replacement after surgery was 
replaced by percutaneous therapy as the primary treatment 
method in his dialysis population. 
Proponents ofpercutaneous therapy cite the following 
advantages: vein preservation for a future access or a revi- 
sion of the current access} ability to treat repetitively with 
percutaneous means without detriment to immediate out- 
come} decreased success of repetitive surgical salvage, 3 
decreased need for temporary central catheters because of 
ready availability of angiography suites as compared with 
operating rooms, and prior knowledge of the underlying 
anatomy from previous contrast studies when surgery 
becomes necessary. 2 All dialysis grafts ultimately will fail 
again regardless of the treatment method. The ideal study 
would compare treatment algorithms, combinations of 
percutaneous and surgical treatments hat depend on the 
lesion location or the graft type. 
The authors are to be commended for proving a theo- 
ry that many surgeons and interventional radiologists have 
believed for a long time: surgical revision or patch angio- 
plasty result in better primary patency rates (no further 
treatment) than balloon angioplasty of a diseased vein. 
Nevertheless, completely ignoring the other benefits of 
percutaneous therapy and discarding the results of previ- 
ous studies is premature and contrary to the opinion of the 
multidisciplinary work group for the Dialysis Outcomes 
Quality Initiative of the National Kidney Foundation. 4 
Richard Gray, MD 
Member, SCVIR 
Washington Hospital Center 
110 Irving St., NW 
Washington, DC 20010-2975 
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Reply 
To the Editors: 
We read with great interest he comments of Dr. Gray 
that concern our recent study} and we appreciate an oppor- 
tunity to respond. Dr. Gray states: "the ultimate long-term 
patency rate of a dialysis access has far greater clinical impor- 
tance than the outcome after treatment of a single episode 
of access thrombosis." We agree. However, the cost 
required to preserve the access has great importance, and so 
the number of procedures required and the results expected 
with each procedure are equally important data. 
Few prospective data have been produced in this area, 
and a number of questions hould be addressed with ran- 
domized trials. The first question should address the pri- 
mary patency rate after procedures that are used to salvage 
thrombosed ialysis access hunts. In our patient popula- 
tion, surgical procedures provided a longer duration of pri- 
mary patency. We agree that the use of repetitive proce- 
dures for maintenance of access patency isan important but 
separate question that we hope will be answered with 
another prospective trial. A multicenter trial would be 
preferable because the results from a single-center p ospec- 
tive trial such as our trial can apply only to similar patient 
populations. However, retrospective studies that use his- 
toric controls, such as the referenced study from Beathard, 
can show good results with a technique in a given patient 
population but cannot show proof of the comparative 
worth of different echniques as was suggested. 
